Latest filing published 16 Jul 2026 for Monte Rosa Therapeutics, Inc., €15k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Jennifer Champoux discloses dealings in Monte Rosa Therapeutics, Inc. to SEC (Form 4). The record holds 12 filings, for trades running from 2 January 2025 to 15 July 2026.
Sales make up the whole of the open-market record (5 sales, €162k). The amount is not disclosed for 2 filings. Besides market trades, the filings include 2 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 5 sales.
Most recently, on 16 July 2026, the filings show an open-market sale worth €89k in Monte Rosa Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations